Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria.
BACKGROUND: Treatments for uncomplicated falciparum malaria should have high cure rates. The World Health Organization has recently set a target cure rate of 95% assessed at 28 days. The use of more effective drugs, with longer periods of patient follow-up, and parasite genotyping to distinguish re...
Prif Awduron: | Stepniewska, K, White, N |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
BioMed Central
2006
|
Eitemau Tebyg
-
Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria
gan: Stepniewska Kasia, et al.
Cyhoeddwyd: (2006-12-01) -
Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria.
gan: Borrmann, S, et al.
Cyhoeddwyd: (2008) -
Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria
gan: Borrmann, S, et al.
Cyhoeddwyd: (2008) -
Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria.
gan: Steffen Borrmann, et al.
Cyhoeddwyd: (2008-11-01) -
Quinine pharmacokinetic-pharmacodynamic relationships in uncomplicated falciparum malaria.
gan: Pukrittayakamee, S, et al.
Cyhoeddwyd: (2003)